Search results
Results from the Health.Zone Content Network
The COVID-19 vaccination program in the Philippines was a mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the pandemic in the country. The vaccination program was initiated by the Duterte administration on March 1, 2021, a ...
An International Certificate of Vaccination or Revaccination Against Yellow Fever, issued in the Soviet Union in 1985. The International Certificate of Inoculation and Vaccination was established by the International Sanitary Convention for Aerial Navigation (1933) in The Hague, which came into force on 1 August 1935 and was amended in 1944. [3]
A COVID-19 vaccine card is a record often given to those who have received a COVID-19 vaccine showing information such as the date (s) one has received the shot (s) and the brand of vaccine one has received, sometimes including the lot number. The card also contains information identifying the recipient and the location where the shot was given.
Philippine government response to the COVID-19 pandemic. In early January 2020, the Philippines confirmed its first case of Novel coronavirus disease. Two months later, the Philippines implemented national lockdowns, mask mandate, and social distancing. In February 2021, COVID-19 vaccines reached the Philippines and began to the administered.
The Oxford–AstraZeneca COVID-19 vaccine, sold under the brand names Vaxzevria[6]and Covishield,[7]is a viral vector vaccine[8]produced by the British University of Oxford, British-Swedish company AstraZeneca, and the Coalition for Epidemic Preparedness Innovations. [8][9][10]Finland, Denmark, and Norway suspended the use of the Oxford ...
The coronavirus disease 2019 (COVID-19) vaccine is important for preventing serious illness and death due to COVID-19. So far, 81.4% of people in the United States have received at least one dose ...
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA). Depending on the jurisdiction, it is authorized for use in ...
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [32] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing. [44] [45] It is authorized for use ...